Results 31 to 40 of about 22,851 (227)

Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study

BMJ Medicine
Objective To determine the balance of costs, risks, and benefits for different thromboprophylaxis strategies for medical patients during hospital admission.Design Decision analysis modelling study.Setting NHS hospitals in England.Population Eligible ...
Daniel Horner, Steve Goodacre, Kerstin de Wit, Beverley J Hunt, Abdullah Pandor, Sarah Davis, Mark Holland, Xavier Luke Griffin   +7 more
doaj   +1 more source

Thromboprophylaxis in Stroke Patients

Stroke, 2005
To the Editor: The risk for venous thromboembolism (VTE) in medical patients, including those with stroke, is similar to that in moderate-risk surgery patients.1 In contrast to surgical patients, prevention of VTE has been less characterized in hospitalized medical patients because trials are generally limited in number and smaller in size.
LIPPI, Giuseppe, GUIDI, Giancesare
openaire   +4 more sources

Computerized Clinical Decision Support to Prevent Venous Thromboembolism among Hospitalized Patients: Proximal Outcomes from a Multiyear Quality Improvement Project

Journal for Healthcare Quality, EarlyView., 2014
Abstract Despite venous thromboembolism (VTE) policy initiatives, gaps exist between guidelines and practice. In response, hospitals implement clinical decision support (CDS) systems to improve VTE prophylaxis. To assess the impact of a VTE CDS on reducing incidence of VTE, this study used a pretest/posttest, longitudinal, cohort design incorporating ...
Robert C. Amland, Bonnie B. Dean, Hsing‐Ting Yu, Hugh Ryan, Timothy Orsund, Jeffrey L. Hackman, Shauna R. Roberts   +6 more
wiley   +1 more source

Efficacy of thromboprophylaxis following stage II surgical palliation for single-ventricle physiology: A systematic review and meta-analysis

Annals of Pediatric Cardiology
Background: Postoperative thrombosis remains a significant cause of mortality and morbidity, especially in patients with single-ventricle physiology (SVP).
Dicky Fakhri, Maura Andini Setiabudi, Ketut Shri Satya Yogananda   +2 more
doaj   +1 more source

Underutilization of pharmacological thromboprophylaxis in obstetrics and gynaecology patients in the absence of a risk assessment tool

Journal of Taibah University Medical Sciences, 2018
Objective: This study was conducted to determine the risk factors for developing venous thromboembolism and to evaluate adherence to thromboprophylaxis guidelines among patients hospitalized in Obstetrics and Gynaecology units.
Galila F. Zaher, FRCPath
doaj   +1 more source

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Clinical and Applied Thrombosis/Hemostasis, 2022
Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE ) . Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during ...
Lucia Stanciakova MD, PhD, Miroslava Dobrotova MD, PhD, Pavol Holly MD, PhD, Jana Zolkova MSc, PhD, Lubica Vadelova MSc, PhD, Ingrid Skornova MA, PhD, Jela Ivankova MSc, Matej Samos MD, PhD, Tomas Bolek MD, PhD, Marian Grendar MSc, PhD, Jan Danko MD, PhD, Peter Kubisz MD, DSc, Jan Stasko MD, PhD   +12 more
doaj   +1 more source

Structural Allograft Reconstruction for Chronic Proximal Hamstring Avulsion Yields Significant Functional Improvement, Acceptable Satisfaction, but Limited Return to Preinjury Sport Levels

Arthroscopy, EarlyView.
Purpose To evaluate midterm outcomes of structural allograft reconstruction in patients with chronic proximal hamstring avulsion injuries. Methods This was a retrospective cohort study (minimum 2‐year follow‐up) including patients who underwent allograft surgical reconstruction for proximal hamstring avulsion injuries between 2016 and 2023. The primary
Nicolas Lefèvre, Mohamad K. Moussa, Eugénie Valentin, Yoann Bohu, Antoine Gerometta, Frederic Khiami, Alain Meyer, Olivier Grimaud, Alexandre Hardy   +8 more
wiley   +1 more source

Thromboprophylaxis practice adequacy.

, 2016
Thromboprophylaxis practice adequacy.
Dominique Mottier (3167157), Guy Meyer (3167172), Antoine Rachas (197007), Catherine Legall (3167175), Pierre Durieux (70854), Grégoire Le Gal (365641), Dominique El Kouri (3167160), Pierre Hausfater (84305), Pierre-Marie Roy (3167169), Jeannot Schmidt (432899), Jean-Marie Chrétien (3167163), Didier Honnart (3167166)   +11 more
core   +1 more source

Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation

Health Technology Assessment, 2019
Background: Thromboprophylaxis can reduce the risk of venous thromboembolism (VTE) during lower-limb immobilisation, but it is unclear whether or not this translates into meaningful health benefit, justifies the risk of bleeding or is cost-effective ...
Abdullah Pandor, Daniel Horner, Sarah Davis, Steve Goodacre, John W Stevens, Mark Clowes, Beverley J Hunt, Tim Nokes, Jonathan Keenan, Kerstin de Wit   +9 more
doaj   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source